212 related articles for article (PubMed ID: 36988891)
1. ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
Yang L; Wang H; Guo M; He M; Zhang W; Zhan M; Liu Y
Cell Oncol (Dordr); 2023 Aug; 46(4):1085-1095. PubMed ID: 36988891
[TBL] [Abstract][Full Text] [Related]
2. ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.
Nakamura T; Nishikawa Y; Shiokawa M; Takeda H; Yokode M; Matsumoto S; Muramoto Y; Ota S; Yoshida H; Okada H; Kuwada T; Marui S; Matsumori T; Maruno T; Uza N; Kodama Y; Hatano E; Seno H
J Pathol; 2023 Sep; 261(1):28-42. PubMed ID: 37345534
[TBL] [Abstract][Full Text] [Related]
3. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
Yu Y; Wang J; Xia N; Li B; Jiang X
Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.
Hu YP; Jin YP; Wu XS; Yang Y; Li YS; Li HF; Xiang SS; Song XL; Jiang L; Zhang YJ; Huang W; Chen SL; Liu FT; Chen C; Zhu Q; Chen HZ; Shao R; Liu YB
Mol Cancer; 2019 Nov; 18(1):167. PubMed ID: 31752906
[TBL] [Abstract][Full Text] [Related]
6. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
Yang C; Xu M; Shen HJ; Zhu HY; Li F; He M; Chen T; Wang J; Shi WJ; Ji F
Int J Clin Exp Pathol; 2014; 7(2):521-8. PubMed ID: 24551272
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
[TBL] [Abstract][Full Text] [Related]
8. Combination of RUNX1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
She C; Wu C; Guo W; Xie Y; Li S; Liu W; Xu C; Li H; Cao P; Yang Y; Wang X; Chang A; Feng Y; Hao J
J Exp Clin Cancer Res; 2023 Sep; 42(1):238. PubMed ID: 37697370
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma.
Xue Z; Yang B; Xu Q; Zhu X; Qin G
Biochem Biophys Res Commun; 2020 Feb; 522(4):952-959. PubMed ID: 31810606
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
Wang FT; Wang H; Wang QW; Pan MS; Li XP; Sun W; Fan YZ
Cancer Chemother Pharmacol; 2020 Aug; 86(2):221-232. PubMed ID: 32654071
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.
Sun QS; Luo M; Zhao HM; Sun H
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4210-4219. PubMed ID: 31173292
[TBL] [Abstract][Full Text] [Related]
12. SOAT1 in gallbladder cancer: Clinicopathological significance and avasimibe therapeutics.
Hong Y; Abudukeremu X; She F; Chen Y
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23733. PubMed ID: 38770938
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
[TBL] [Abstract][Full Text] [Related]
14. Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate.
Pandey A; Stawiski EW; Durinck S; Gowda H; Goldstein LD; Barbhuiya MA; Schröder MS; Sreenivasamurthy SK; Kim SW; Phalke S; Suryamohan K; Lee K; Chakraborty P; Kode V; Shi X; Chatterjee A; Datta K; Khan AA; Subbannayya T; Wang J; Chaudhuri S; Gupta S; Shrivastav BR; Jaiswal BS; Poojary SS; Bhunia S; Garcia P; Bizama C; Rosa L; Kwon W; Kim H; Han Y; Yadav TD; Ramprasad VL; Chaudhuri A; Modrusan Z; Roa JC; Tiwari PK; Jang JY; Seshagiri S
Nat Commun; 2020 Aug; 11(1):4225. PubMed ID: 32839463
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
Xu S; Jiang C; Lin R; Wang X; Hu X; Chen W; Chen X; Chen T
J Exp Clin Cancer Res; 2021 Nov; 40(1):373. PubMed ID: 34823564
[TBL] [Abstract][Full Text] [Related]
17. HASPIN is involved in the progression of gallbladder carcinoma.
Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
[TBL] [Abstract][Full Text] [Related]
18. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
[TBL] [Abstract][Full Text] [Related]
19. ELF3-AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood.
Song S; He X; Wang J; Wang R; Wang L; Zhao W; Wang Y; Zhang Y; Yu Z; Miao D; Xue Y
Cancer Sci; 2021 Nov; 112(11):4553-4569. PubMed ID: 34418240
[TBL] [Abstract][Full Text] [Related]
20. PKMYT1: A Potential Target for CCNE1 Amplificated Colorectal Tumors.
Fang Y; Zhang X; Guo Y; Dong Y; Liu W; Hu X; Li X; Gao D
Cell Biochem Biophys; 2023 Sep; 81(3):569-576. PubMed ID: 37572218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]